title: Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study.
authors.forename: T-Y
authors.initials: TY
authors.lastname: Tzung
authors.forename: Y-S
authors.initials: YS
authors.lastname: Liu
authors.forename: H-W
authors.initials: HW
authors.lastname: Chang
mesh_terms: D000328:Adult; D002990:Clobetasol / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005148:Facial Dermatoses / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy*; D008297:Male; D009824:Ointments; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D009824:Ointments; D002990:Clobetasol; D016559:Tacrolimus